Chronic cough, defined as a cough lasting more than eight weeks, presents a common yet complex challenge in clinical practice. Despite its prevalence, the etiology often remains elusive, leading to diagnostic uncertainty and therapeutic dilemmas. This article aims to illuminate a comprehensive approach to diagnosing and managing chronic cough.
Chronic cough can be attributed to a myriad of causes, from common conditions like asthma, gastroesophageal reflux disease (GERD), and upper airway cough syndrome (UACS) to less prevalent etiologies like lung cancer. A detailed patient history coupled with targeted investigations can help pinpoint the underlying cause.
The diagnostic approach should be systematic and patient-centric. Initial evaluation should include a thorough history and physical examination, focusing on identifying common causes and risk factors. If the cause is not readily apparent, further investigations such as imaging, spirometry, and bronchoscopy may be warranted. Empirical therapy can be considered in certain cases, but should not delay definitive diagnosis.
Management should be tailored based on the identified etiology. For instance, asthma-related cough may respond well to inhaled corticosteroids, while GERD-associated cough may require proton pump inhibitors. Non-pharmacological interventions, such as lifestyle modifications and physiotherapy, can also play a crucial role. Refractory cases may necessitate referral to a specialist.
Research is ongoing to develop novel diagnostic tools and therapeutic options for chronic cough. Emerging modalities like cough reflex testing and potential new drugs targeting neural pathways are promising. More studies are needed to validate their efficacy and safety.
Chronic cough is a multifaceted problem requiring a comprehensive and individualized approach. By maintaining a high index of suspicion, employing a systematic diagnostic strategy, and tailoring management based on etiology, clinicians can effectively diagnose and manage this common but often perplexing condition.
1.
An individual state lost $4.02 billion due to untreated mental illness.
2.
Antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer
3.
Black Canadians Face Multiple Barriers to Blood Donation
4.
Study: Discovery of cellular identity may influence cancer treatment
5.
Early-life exposure to air and light pollution linked to increased risk of pediatric thyroid cancer
1.
Drug Safety Through Oncology Survivorship Medication Monitoring Frameworks
2.
Digital Oncology Navigation Systems for Coordinated Multidisciplinary Cancer Care
3.
Simulation for Hematology Emergencies: Enhancing Clinical Preparedness and Patient Outcomes
4.
Colon Cancer Staging: What You Need to Know
5.
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
How Multidisciplinary Teams Support Modern Cancer Care
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Navigating the Complexities of Ph Negative ALL - Part II
4.
Navigating the Complexities of Ph Negative ALL - Part VIII
5.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation